FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Charlie Fuchs

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Physiology

DNA Methylation

Co-author Network

Publications

TOP 3
M Song; K Wu; Charlie S Fuchs; Edward L Giovannucci; S Ogino; Andrew T Chan
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
X Zhang; Charlie S Fuchs; E L Giovannucci; M Pollak; S A Smith-Warner; Walter C Willett; K Wu; J Ma
Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study.
Brian C Jacobson; Edward L Giovannucci; Charlie S Fuchs
Smoking and Barrett's esophagus in women who undergo upper endoscopy.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Charlie Fuchs (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: M Song; K Wu; Charlie S Fuchs; Edward L Giovannucci; S Ogino; Andrew T Chan
A prospective study of plasma inflammatory markers and risk of colorectal cancer in men.
British journal of cancer 2013;108(9):1891-8.
2012: X Zhang; Charlie S Fuchs; E L Giovannucci; M Pollak; S A Smith-Warner; Walter C Willett; K Wu; J Ma
Magnesium intake, plasma C-peptide, and colorectal cancer incidence in US women: a 28-year follow-up study.
British journal of cancer 2012;106(7):1335-41.
2011: Brian C Jacobson; Edward L Giovannucci; Charlie S Fuchs
Smoking and Barrett's esophagus in women who undergo upper endoscopy.
Digestive diseases and sciences 2011;56(6):1707-17.
2011: J A Chan; Lawrence S Blaszkowsky; Peter C Enzinger; David P Ryan; Thomas A Abrams; Andrew X Zhu; Jennifer S Temel; D Schrag; Pankaj Bhargava; Jeffrey A Meyerhardt; Brian M Wolpin; Panos Fidias; H Zheng; S Florio; E Regan; Charlie S Fuchs
A multicenter phase II trial of single-agent cetuximab in advanced esophageal and gastric adenocarcinoma.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2011;22(6):1367-73.
2010: Brian M Wolpin; Christopher Kabrhel; Raphaëlle Varraso; Peter Kraft; Eric B Rimm; Samuel Z Goldhaber; Carlos A Camargo; Charlie S Fuchs
Prospective study of ABO blood type and the risk of pulmonary embolism in two large cohort studies.
Thrombosis and haemostasis 2010;104(5):962-71.
2010: Kimmie Ng; Jeffrey A Meyerhardt; Jennifer A Chan; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Al B Benson; Paul L Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Charlie S Fuchs
Multivitamin use is not associated with cancer recurrence or survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(28):4354-63.
2010: Y Baba; Katsuhiko Nosho; K Shima; Jeffrey A Meyerhardt; A T Chan; Jeffrey A Engelman; Lewis C Cantley; Massimo Loda; E Giovannucci; Charlie S Fuchs; Shuji Ogino
Prognostic significance of AMP-activated protein kinase expression and modifying effect of MAPK3/1 in colorectal cancer.
British journal of cancer 2010;103(7):1025-33.
2010: Howard L McLeod; Daniel J Sargent; Sharon Marsh; Erin M Green; Cristi R King; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Stephen N Thibodeau; Axel Grothey; Roscoe F Morton; Richard M Goldberg
Pharmacogenetic predictors of adverse events and response to chemotherapy in metastatic colorectal cancer: results from North American Gastrointestinal Intergroup Trial N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(20):3227-33.
2010: Y Bao; Kimmie Ng; Brian M Wolpin; Dominique S Michaud; Edward Giovannucci; Charlie S Fuchs
Predicted vitamin D status and pancreatic cancer risk in two prospective cohort studies.
British journal of cancer 2010;102(9):1422-7.
2009: Shuji Ogino; Jeffrey A Meyerhardt; Natsumi Irahara; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Paul Schaefer; Renaud Whittom; Alexander Hantel; Al B Benson; Richard M Goldberg; Monica M Bertagnolli; Charlie S Fuchs
KRAS mutation in stage III colon cancer and clinical outcome following intergroup trial CALGB 89803.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(23):7322-9.
2009: Brian C Jacobson; A T Chan; E L Giovannucci; Charlie S Fuchs
Body mass index and Barrett's oesophagus in women.
Gut 2009;58(11):1460-6.
2009: Esther K Wei; GRaham Colditz; Edward L Giovannucci; Charlie S Fuchs; Bernard A Rosner
Cumulative risk of colon cancer up to age 70 years by risk factor status using data from the Nurses' Health Study.
American journal of epidemiology 2009;170(7):863-72.
2009: Jeffrey A Meyerhardt; Shuji Ogino; Gregory J Kirkner; Andrew T Chan; Brian M Wolpin; Kimmie Ng; Katsuhiko Nosho; Kaori Shima; Edward L Giovannucci; Massimo Loda; Charlie S Fuchs
Interaction of molecular markers and physical activity on mortality in patients with colon cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(18):5931-6.
2009: Kimmie Ng; Brian M Wolpin; Jeffrey A Meyerhardt; K Wu; A T Chan; Bruce W Hollis; Edward L Giovannucci; Meir J Stampfer; Walter C Willett; Charlie S Fuchs
Prospective study of predictors of vitamin D status and survival in patients with colorectal cancer.
British journal of cancer 2009;101(6):916-23.
2009: Andrew X Zhu; Dushyant V Sahani; Dan G Duda; Emmanuelle di Tomaso; Marek Ancukiewicz; Onofrio A Catalano; Vivek Sindhwani; Lawrence S Blaszkowsky; Sam S Yoon; Johanna Lahdenranta; Pankaj Bhargava; Jeffrey A Meyerhardt; Jeffrey W Clark; Eunice L Kwak; Aram F Hezel; Rebecca Miksad; Thomas A Abrams; Peter C Enzinger; Charlie S Fuchs; David P Ryan; Rakesh K Jain
Efficacy, safety, and potential biomarkers of sunitinib monotherapy in advanced hepatocellular carcinoma: a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(18):3027-35.
2009: Brian M Wolpin; Andrew T Chan; Patricia Hartge; STEPHEN CHANOCK; Peter Kraft; David J Hunter; Edward L Giovannucci; Charlie S Fuchs
ABO blood group and the risk of pancreatic cancer.
Journal of the National Cancer Institute 2009;101(6):424-31.
2009: Jeanine Genkinger; Donna Spiegelman; Kristin E Anderson; Leif Bergkvist; Leslie Bernstein; Piet A van den Brandt; Dallas R English; Jo L Freudenheim; Charlie S Fuchs; Graham G Giles; Edward Giovannucci; Susan E Hankinson; Pamela L Horn-Ross; Michael F Leitzmann; Satu Männistö; James R Marshall; Marjorie L McCullough; Anthony B Miller; Douglas J Reding; Kim Robien; Thomas E Rohan; Arthur Schatzkin; Victoria L Stevens; Rachael Stolzenberg-Solomon; Bas A J Verhage; Alicja Wolk; Regina G Ziegler; Stephanie A Smith-Warner
Alcohol intake and pancreatic cancer risk: a pooled analysis of fourteen cohort studies.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2009;18(3):765-76.
2009: Peter C Enzinger; David P Ryan; jeffrey clark; Alona Muzikansky; Craig C Earle; Matthew H Kulke; Jeffrey A Meyerhardt; Lawrence S Blaszkowsky; Andrew X Zhu; Panos Fidias; Michele Vincitore; Robert J Mayer; Charlie S Fuchs
Weekly docetaxel, cisplatin, and irinotecan (TPC): results of a multicenter phase II trial in patients with metastatic esophagogastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2009;20(3):475-80.
2009: Brian M Wolpin; Jeffrey A Meyerhardt; Andrew T Chan; Kimmie Ng; Jennifer A Chan; Kana Wu; Michael N Pollak; Edward L Giovannucci; Charlie S Fuchs
Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):176-85.
2009: Brian M Wolpin; Aram F Hezel; Thomas Abrams; Lawrence S Blaszkowsky; Jeffrey A Meyerhardt; Jennifer A Chan; Peter C Enzinger; Brittany Allen; jeffrey clark; David P Ryan; Charlie S Fuchs
Oral mTOR inhibitor everolimus in patients with gemcitabine-refractory metastatic pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(2):193-8.
2008: Hanna Sanoff; Daniel J Sargent; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Five-year data and prognostic factor analysis of oxaliplatin and irinotecan combinations for advanced colorectal cancer: N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(35):5721-7.
2008: Katsuhiko Nosho; Takako Kawasaki; A T Chan; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Charlie S Fuchs; Shuji Ogino
Cyclin D1 is frequently overexpressed in microsatellite unstable colorectal cancer, independent of CpG island methylator phenotype.
Histopathology 2008;53(5):588-98.
2008: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Impact of body mass index and weight change after treatment on cancer recurrence and survival in patients with stage III colon cancer: findings from Cancer and Leukemia Group B 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(25):4109-15.
2008: Lau Caspar Thygesen; Morten Grønbaek; Christoffer Johansen; Charlie S Fuchs; Walter C Willett; Edward Giovannucci
Prospective weight change and colon cancer risk in male US health professionals.
International journal of cancer. Journal international du cancer 2008;123(5):1160-5.
2008: Matthew H Kulke; Heinz-Josef Lenz; Neal J Meropol; James Posey; David P Ryan; Joel Picus; Emily K Bergsland; Keith Stuart; Lesley Tye; Xin Huang; Jim Z Li; Charles M Baum; Charlie S Fuchs
Activity of sunitinib in patients with advanced neuroendocrine tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(20):3403-10.
2008: Brian M Wolpin; Esther K Wei; Kimmie Ng; Jeffrey A Meyerhardt; Jennifer A Chan; Jacob Selhub; Edward L Giovannucci; Charlie S Fuchs
Prediagnostic plasma folate and the risk of death in patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(19):3222-8.
2008: Kimmie Ng; Jeffrey A Meyerhardt; Kana Wu; Diane Feskanich; Bruce W Hollis; Edward L Giovannucci; Charlie S Fuchs
Circulating 25-hydroxyvitamin d levels and survival in patients with colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(18):2984-91.
2008: Shuji Ogino; Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Charlie S Fuchs
LINE-1 hypomethylation is inversely associated with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
International journal of cancer. Journal international du cancer 2008;122(12):2767-73.
2008: Jennifer A Chan; Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Paul Schaefer; Renaud Whittom; Alexander Hantel; Richard M Goldberg; Robert S Warren; Monica Bertagnolli; Charlie S Fuchs
Association of family history with cancer recurrence and survival among patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2008;299(21):2515-23.
2008: Katsuhiko Nosho; Takako Kawasaki; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Dimity Zepf; Liying Yan; Janina A Longtine; Charlie S Fuchs; Shuji Ogino
PIK3CA mutation in colorectal cancer: relationship with genetic and epigenetic alterations.
Neoplasia (New York, N.Y.) 2008;10(6):534-41.
2008: Lau Caspar Thygesen; Kana Wu; Morten Grønbaek; Charlie S Fuchs; Walter C Willett; Edward Giovannucci
Alcohol intake and colorectal cancer: a comparison of approaches for including repeated measures of alcohol consumption.
Epidemiology (Cambridge, Mass.) 2008;19(2):258-64.
2008: Takako Kawasaki; Mutsuko Ohnishi; Katsuhiko Nosho; Yuko Suemoto; Gregory J Kirkner; Jeffrey A Meyerhardt; Charlie S Fuchs; Shuji Ogino
CpG island methylator phenotype-low (CIMP-low) colorectal cancer shows not only few methylated CIMP-high-specific CpG islands, but also low-level methylation at individual loci.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(3):245-55.
2008: Aditi Hazra; STEPHEN CHANOCK; Edward Giovannucci; David G Cox; Tianhua Niu; Charlie S Fuchs; Walter C Willett; David J Hunter
Large-scale evaluation of genetic variants in candidate genes for colorectal cancer risk in the Nurses' Health Study and the Health Professionals' Follow-up Study.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2008;17(2):311-9.
2008: Charlie S Fuchs; John Marshall; José Barrueco
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: updated results from the BICC-C study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(4):689-90.
2008: Takako Kawasaki; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Zhiqian Liu; Hiroyuki Yamamoto; Massimo Loda; Charlie S Fuchs; Shuji Ogino
WRN promoter methylation possibly connects mucinous differentiation, microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2008;21(2):150-8.
2008: Jeffrey A Meyerhardt; Andrew X Zhu; Keith Stuart; David P Ryan; Lawrence S Blaszkowsky; Nicole Lehman; Craig C Earle; Matthew H Kulke; Pankaj Bhargava; Charlie S Fuchs
Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer.
Digestive diseases and sciences 2008;53(2):564-70.
2008: Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Jonathan N Glickman; Andrew T Chan; Gregory J Kirkner; Mari Mino-Kenudson; Charlie S Fuchs; Shuji Ogino
Cyclooxygenase-2 overexpression is common in serrated and non-serrated colorectal adenoma, but uncommon in hyperplastic polyp and sessile serrated polyp/adenoma.
BMC cancer 2008;8():33.
2008: Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Eva S Schernhammer; Kana Wu; Charlie S Fuchs
Aspirin dose and duration of use and risk of colorectal cancer in men.
Gastroenterology 2008;134(1):21-8.
2007: Kathleen Wolin; I-Min Lee; GRaham Colditz; Robert J Glynn; Charlie S Fuchs; Edward Giovannucci
Leisure-time physical activity patterns and risk of colon cancer in women.
International journal of cancer. Journal international du cancer 2007;121(12):2776-81.
2007: Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Charlie S Fuchs; Shuji Ogino
IGFBP3 promoter methylation in colorectal cancer: relationship with microsatellite instability, CpG island methylator phenotype, and p53.
Neoplasia (New York, N.Y.) 2007;9(12):1091-8.
2007: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Yuko Suemoto; Jeffrey A Meyerhardt; Charlie S Fuchs
Molecular correlates with MGMT promoter methylation and silencing support CpG island methylator phenotype-low (CIMP-low) in colorectal cancer.
Gut 2007;56(11):1564-71.
2007: Matthew H Kulke; Lawrence S Blaszkowsky; David P Ryan; jeffrey clark; Jeffrey A Meyerhardt; Andrew X Zhu; Peter C Enzinger; Eunice L Kwak; Alona Muzikansky; Colleen Lawrence; Charlie S Fuchs
Capecitabine plus erlotinib in gemcitabine-refractory advanced pancreatic cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4787-92.
2007: Charlie S Fuchs; John Marshall; Edith Mitchell; Rafal Wierzbicki; Vinod Ganju; Mark Jeffery; Joseph Schulz; Donald Richards; Raoudha Soufi-Mahjoubi; Benjamin Wang; José Barrueco
Randomized, controlled trial of irinotecan plus infusional, bolus, or oral fluoropyrimidines in first-line treatment of metastatic colorectal cancer: results from the BICC-C Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(30):4779-86.
2007: Paul F Engstrom; J Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Dayna S Early; Marwan G Fakih; Charlie S Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Leonard B Saltz; David Shibata; John M Skibber; Alan P Venook
Rectal cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(9):940-81.
2007: Paul F Engstrom; J Pablo Arnoletti; Al B Benson; Yi-Jen Chen; Michael A Choti; Harry S Cooper; Raza A Dilawari; Dayna S Early; Marwan G Fakih; Charlie S Fuchs; Jean L Grem; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Leonard B Saltz; David Shibata; John M Skibber; Alan P Venook
Colon cancer.
Journal of the National Comprehensive Cancer Network : JNCCN 2007;5(9):884-925.
2007: Dominique S Michaud; Brian M Wolpin; Ed Giovannucci; Simin Liu; Barbara Cochrane; JoAnn E Manson; Michael N Pollak; Jing Ma; Charlie S Fuchs
Prediagnostic plasma C-peptide and pancreatic cancer risk in men and women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2007;16(10):2101-9.
2007: Jeffrey A Meyerhardt; jeffrey clark; Jeffrey G Supko; Joseph P Eder; Shuji Ogino; Clinton F Stewart; Ferdinando D'Amato; Janet Dancey; Peter C Enzinger; Andrew X Zhu; David P Ryan; Craig C Earle; Robert J Mayer; Ann Michelini; Kate Kinsella; Charlie S Fuchs
Phase I study of gefitinib, irinotecan, 5-fluorouracil and leucovorin in patients with metastatic colorectal cancer.
Cancer chemotherapy and pharmacology 2007;60(5):661-70.
2007: Fengfei Wang; Lilin Wang; Christine Briggs; Ewa Sicinska; Sandra M Gaston; Harvey J Mamon; Matthew H Kulke; Raffaella Zamponi; Massimo Loda; Elizabeth Maher; Shuji Ogino; Charlie S Fuchs; Jin Li; Carlos Hader; Michael G Makrigiorgos
DNA degradation test predicts success in whole-genome amplification from diverse clinical samples.
The Journal of molecular diagnostics : JMD 2007;9(4):441-51.
2007: Shuji Ogino; Aditi Hazra; Gregory J Tranah; Gregory J Kirkner; Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Jeffrey A Meyerhardt; David J Hunter; Charlie S Fuchs
MGMT germline polymorphism is associated with somatic MGMT promoter methylation and gene silencing in colorectal cancer.
Carcinogenesis 2007;28(9):1985-90.
2007: Brian M Wolpin; Dominique S Michaud; Edward L Giovannucci; Eva S Schernhammer; Meir J Stampfer; JoAnn E Manson; Barbara Cochrane; Thomas E Rohan; Jing Ma; Michael N Pollak; Charlie S Fuchs
Circulating insulin-like growth factor binding protein-1 and the risk of pancreatic cancer.
Cancer research 2007;67(16):7923-8.
2007: Jeffrey A Meyerhardt; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Frank B Hu; Robert J Mayer; Heidi Nelson; Renaud Whittom; Alexander Hantel; James P Thomas; Charlie S Fuchs
Association of dietary patterns with cancer recurrence and survival in patients with stage III colon cancer.
JAMA : the journal of the American Medical Association 2007;298(7):754-64.
2007: Eunyoung Cho; Walter C Willett; GRaham Colditz; Charlie S Fuchs; Kana Wu; Andrew T Chan; Steven H Zeisel; Edward L Giovannucci
Dietary choline and betaine and the risk of distal colorectal adenoma in women.
Journal of the National Cancer Institute 2007;99(16):1224-31.
2007: Grace K Dy; James E Krook; Erin M Green; Daniel J Sargent; Thierry Delaunoit; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Barbara A Pockaj; Robert P Sticca; Steven R Alberts; Henry C Pitot; Richard M Goldberg
Impact of complete response to chemotherapy on overall survival in advanced colorectal cancer: results from Intergroup N9741.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(23):3469-74.
2007: Andrew X Zhu; Keith Stuart; Lawrence S Blaszkowsky; Alona Muzikansky; Donald P Reitberg; jeffrey clark; Peter C Enzinger; Pankaj Bhargava; Jeffrey A Meyerhardt; Kerry Horgan; Charlie S Fuchs; David P Ryan
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma.
Cancer 2007;110(3):581-9.
2007: Amanda C Ashley; Daniel J Sargent; Steven R Alberts; Axel Grothey; Megan E Campbell; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Richard M Goldberg
Updated efficacy and toxicity analysis of irinotecan and oxaliplatin (IROX) : intergroup trial N9741 in first-line treatment of metastatic colorectal cancer.
Cancer 2007;110(3):670-7.
2007: Kana Wu; Diane Feskanich; Charlie S Fuchs; Walter C Willett; Bruce W Hollis; Edward L Giovannucci
A nested case control study of plasma 25-hydroxyvitamin D concentrations and risk of colorectal cancer.
Journal of the National Cancer Institute 2007;99(14):1120-9.
2007: Brian M Wolpin; Dominique S Michaud; Edward L Giovannucci; Eva S Schernhammer; Meir J Stampfer; JoAnn E Manson; Barbara Cochrane; Thomas E Rohan; Jing Ma; Michael N Pollak; Charlie S Fuchs
Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts.
British journal of cancer 2007;97(1):98-104.
2007: Takako Kawasaki; Katsuhiko Nosho; Mutsuko Ohnishi; Yuko Suemoto; Gregory J Kirkner; Reiko Dehari; Jeffrey A Meyerhardt; Charlie S Fuchs; Shuji Ogino
Correlation of beta-catenin localization with cyclooxygenase-2 expression and CpG island methylator phenotype (CIMP) in colorectal cancer.
Neoplasia (New York, N.Y.) 2007;9(7):569-77.
2007: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Peter Kraft; Massimo Loda; Charlie S Fuchs
Evaluation of markers for CpG island methylator phenotype (CIMP) in colorectal cancer by a large population-based sample.
The Journal of molecular diagnostics : JMD 2007;9(3):305-14.
2007: Jeffrey A Meyerhardt; Keith Stuart; Charlie S Fuchs; Andrew X Zhu; Craig C Earle; Pankaj Bhargava; Lawrence S Blaszkowsky; Peter C Enzinger; Robert J Mayer; S Battu; C Lawrence; David P Ryan
Phase II study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(7):1185-9.
2007: Aditi Hazra; Kana Wu; Peter Kraft; Charlie S Fuchs; Edward L Giovannucci; David J Hunter
Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study.
Carcinogenesis 2007;28(7):1510-9.
2007: Eva S Schernhammer; Brian M Wolpin; Nader Rifai; Barbara Cochrane; JoAnn E Manson; Jing Ma; Ed Giovannucci; Cynthia Thomson; Meir J Stampfer; Charlie S Fuchs
Plasma folate, vitamin B6, vitamin B12, and homocysteine and pancreatic cancer risk in four large cohorts.
Cancer research 2007;67(11):5553-60.
2007: Shuji Ogino; Takako Kawasaki; Akiyo Ogawa; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Fatty acid synthase overexpression in colorectal cancer is associated with microsatellite instability, independent of CpG island methylator phenotype.
Human pathology 2007;38(6):842-9.
2007: Andrew T Chan; Shuji Ogino; Charlie S Fuchs
Aspirin and the risk of colorectal cancer in relation to the expression of COX-2.
The New England journal of medicine 2007;356(21):2131-42.
2007: Kyungwon Oh; Walter C Willett; Kana Wu; Charlie S Fuchs; Edward L Giovannucci
Calcium and vitamin D intakes in relation to risk of distal colorectal adenoma in women.
American journal of epidemiology 2007;165(10):1178-86.
2007: Kimmie Ng; Jeffrey A Meyerhardt; Charlie S Fuchs
Adjuvant and neoadjuvant approaches in gastric cancer.
Cancer journal (Sudbury, Mass.) 2007;13(3):168-74.
2007: Shuji Ogino; Jeffrey A Meyerhardt; Takako Kawasaki; jeffrey clark; David P Ryan; Matthew H Kulke; Peter C Enzinger; Brian M Wolpin; Massimo Loda; Charlie S Fuchs
CpG island methylation, response to combination chemotherapy, and patient survival in advanced microsatellite stable colorectal carcinoma.
Virchows Archiv : an international journal of pathology 2007;450(5):529-37.
2007: Shuji Ogino; Takako Kawasaki; Akiyo Ogawa; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
TGFBR2 mutation is correlated with CpG island methylator phenotype in microsatellite instability-high colorectal cancer.
Human pathology 2007;38(4):614-20.
2007: Shuji Ogino; Takako Kawasaki; Akiyo Ogawa; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Cytoplasmic localization of p27 (cyclin-dependent kinase inhibitor 1B/KIP1) in colorectal cancer: inverse correlations with nuclear p27 loss, microsatellite instability, and CpG island methylator phenotype.
Human pathology 2007;38(4):585-92.
2007: Andrew T Chan; JoAnn E Manson; Diane Feskanich; Meir J Stampfer; GRaham Colditz; Charlie S Fuchs
Long-term aspirin use and mortality in women.
Archives of internal medicine 2007;167(6):562-72.
2007: Peter C Enzinger; Jacqueline K Benedetti; Jeffrey A Meyerhardt; Sheryl McCoy; Scott A Hundahl; John S Macdonald; Charlie S Fuchs
Impact of hospital volume on recurrence and survival after surgery for gastric cancer.
Annals of surgery 2007;245(3):426-34.
2007: Satu Männistö; Shiaw-Shyuan Yaun; David J Hunter; Donna Spiegelman; Hans-Olov Adami; Demetrius Albanes; Piet A van den Brandt; Julie E Buring; James Cerhan; GRaham Colditz; Jo L Freudenheim; Charlie S Fuchs; Edward Giovannucci; R Alexandra Goldbohm; Lisa Harnack; Michael F Leitzmann; Marjorie L McCullough; Anthony B Miller; Thomas E Rohan; Arthur Schatzkin; Jarmo Virtamo; Walter C Willett; Alicja Wolk; Shumin M Zhang; Stephanie A Smith-Warner
Dietary carotenoids and risk of colorectal cancer in a pooled analysis of 11 cohort studies.
American journal of epidemiology 2007;165(3):246-55.
2007: Andrew X Zhu; jeffrey clark; David P Ryan; Jeffrey A Meyerhardt; Peter C Enzinger; Craig C Earle; Charlie S Fuchs; Eileen Regan; Hiroshi Anbe; Michele Houghton; Joshua Zhang; Peter Urrea; Matthew H Kulke
Phase I and pharmacokinetic study of S-1 administered for 14 days in a 21-day cycle in patients with advanced upper gastrointestinal cancer.
Cancer chemotherapy and pharmacology 2007;59(3):285-93.
2007: Dominique S Michaud; Kaumudi J Joshipura; Edward Giovannucci; Charlie S Fuchs
A prospective study of periodontal disease and pancreatic cancer in US male health professionals.
Journal of the National Cancer Institute 2007;99(2):171-5.
2007: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Mutsuko Ohnishi; Charlie S Fuchs
18q loss of heterozygosity in microsatellite stable colorectal cancer is correlated with CpG island methylator phenotype-negative (CIMP-0) and inversely with CIMP-low and CIMP-high.
BMC cancer 2007;7():72.
2007: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Taiki Yamaji; Massimo Loda; Charlie S Fuchs
Loss of nuclear p27 (CDKN1B/KIP1) in colorectal cancer is correlated with microsatellite instability and CIMP.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2007;20(1):15-22.
2006: Jennifer A Chan; Jeffrey A Meyerhardt; Andrew T Chan; Edward L Giovannucci; GRaham Colditz; Charlie S Fuchs
Hormone replacement therapy and survival after colorectal cancer diagnosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(36):5680-6.
2006: Anita Koushik; Peter Kraft; Charlie S Fuchs; Susan E Hankinson; Walter C Willett; Edward L Giovannucci; David J Hunter
Nonsynonymous polymorphisms in genes in the one-carbon metabolism pathway and associations with colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(12):2408-17.
2006: Balraj S Jhawar; Charlie S Fuchs; GRaham Colditz; Meir J Stampfer
Cardiovascular risk factors for physician-diagnosed lumbar disc herniation.
The spine journal : official journal of the North American Spine Society 2006;6(6):684-91.
2006: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
CpG island methylator phenotype-low (CIMP-low) in colorectal cancer: possible associations with male sex and KRAS mutations.
The Journal of molecular diagnostics : JMD 2006;8(5):582-8.
2006: Charlie S Fuchs; Edith P Mitchell; Paulo M Hoff
Irinotecan in the treatment of colorectal cancer.
Cancer treatment reviews 2006;32(7):491-503.
2006: Anita Koushik; Gregory J Tranah; Jing Ma; Meir J Stampfer; Howard D Sesso; Charlie S Fuchs; Edward L Giovannucci; David J Hunter
p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer.
International journal of cancer. Journal international du cancer 2006;119(8):1863-8.
2006: Jennifer Lin; Shumin M Zhang; Kana Wu; Walter C Willett; Charlie S Fuchs; Edward Giovannucci
Flavonoid intake and colorectal cancer risk in men and women.
American journal of epidemiology 2006;164(7):644-51.
2006: Shuji Ogino; Takako Kawasaki; Gregory J Kirkner; Akiyo Ogawa; I Dorfman; Massimo Loda; Charlie S Fuchs
Down-regulation of p21 (CDKN1A/CIP1) is inversely associated with microsatellite instability and CpG island methylator phenotype (CIMP) in colorectal cancer.
The Journal of pathology 2006;210(2):147-54.
2006: Brian M Wolpin; jeffrey clark; Jeffrey A Meyerhardt; Craig C Earle; David P Ryan; Peter C Enzinger; Andrew X Zhu; Lawrence S Blaszkowsky; Subha Battu; Charlie S Fuchs
Phase I study of gefitinib plus FOLFIRI in previously untreated patients with metastatic colorectal cancer.
Clinical colorectal cancer 2006;6(3):208-13.
2006: Halcyon Skinner; Dominique S Michaud; Edward Giovannucci; Walter C Willett; GRaham Colditz; Charlie S Fuchs
Vitamin D intake and the risk for pancreatic cancer in two cohort studies.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(9):1688-95.
2006: Shuji Ogino; Robert D Odze; Takako Kawasaki; Mohan Brahmandam; Gregory J Kirkner; Peter W Laird; Massimo Loda; Charlie S Fuchs
Correlation of pathologic features with CpG island methylator phenotype (CIMP) by quantitative DNA methylation analysis in colorectal carcinoma.
The American journal of surgical pathology 2006;30(9):1175-83.
2006: Richard M Goldberg; Herbert I Hurwitz; Charlie S Fuchs
The role of targeted therapy in the treatment of colorectal cancer.
Clinical advances in hematology & oncology : H&O 2006;4(8 Suppl 17):1-10; quiz 11-2.
2006: Matthew H Kulke; Emily K Bergsland; David P Ryan; Peter C Enzinger; Thomas J Lynch; Andrew X Zhu; Jeffrey A Meyerhardt; John V Heymach; William E Fogler; Carolyn Sidor; Ann Michelini; Kate Kinsella; Alan P Venook; Charlie S Fuchs
Phase II study of recombinant human endostatin in patients with advanced neuroendocrine tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3555-61.
2006: Jeffrey A Meyerhardt; Edward L Giovannucci; Michelle D Holmes; Andrew T Chan; Jennifer A Chan; GRaham Colditz; Charlie S Fuchs
Physical activity and survival after colorectal cancer diagnosis.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3527-34.
2006: Jeffrey A Meyerhardt; Denise Heseltine; Donna Niedzwiecki; Donna Hollis; Leonard B Saltz; Robert J Mayer; James P Thomas; Heidi Nelson; Renaud Whittom; Alexander Hantel; Richard L Schilsky; Charlie S Fuchs
Impact of physical activity on cancer recurrence and survival in patients with stage III colon cancer: findings from CALGB 89803.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(22):3535-41.
2006: Shuji Ogino; Mohan Brahmandam; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Epigenetic profiling of synchronous colorectal neoplasias by quantitative DNA methylation analysis.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(8):1083-90.
2006: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven Alberts
Randomized controlled trial of reduced-dose bolus fluorouracil plus leucovorin and irinotecan or infused fluorouracil plus leucovorin and oxaliplatin in patients with previously untreated metastatic colorectal cancer: a North American Intergroup Trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3347-53.
2006: Eunice L Kwak; Janusz Jankowski; Sarah P Thayer; Gregory Y Lauwers; Brian W Brannigan; Patricia Neal; Ross A Okimoto; Sara M Haserlat; David R Driscoll; David Ferry; Beth Muir; Jeffrey Settleman; Charlie S Fuchs; Matthew H Kulke; David P Ryan; jeffrey clark; Dennis C Sgroi; Daniel A Haber; Daphne W Bell
Epidermal growth factor receptor kinase domain mutations in esophageal and pancreatic adenocarcinomas.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(14 Pt 1):4283-7.
2006: Shuji Ogino; Mami Cantor; Takako Kawasaki; Mohan Brahmandam; Gregory J Kirkner; Daniel J Weisenberger; Mihaela Campan; Peter W Laird; Massimo Loda; Charlie S Fuchs
CpG island methylator phenotype (CIMP) of colorectal cancer is best characterised by quantitative DNA methylation analysis and prospective cohort studies.
Gut 2006;55(7):1000-6.
2006: Matthew H Kulke; Bingyan Wu; David P Ryan; Peter C Enzinger; Andrew X Zhu; jeffrey clark; Craig C Earle; Ann Michelini; Charlie S Fuchs
A phase II trial of irinotecan and cisplatin in patients with metastatic neuroendocrine tumors.
Digestive diseases and sciences 2006;51(6):1033-8.
2006: Shuji Ogino; Mohan Brahmandam; Takako Kawasaki; Gregory J Kirkner; Massimo Loda; Charlie S Fuchs
Combined analysis of COX-2 and p53 expressions reveals synergistic inverse correlations with microsatellite instability and CpG island methylator phenotype in colorectal cancer.
Neoplasia (New York, N.Y.) 2006;8(6):458-64.
2006: Matthew H Kulke; Alona Muzikansky; Jeffrey Clark; Peter C Enzinger; Panos Fidias; Kate Kinsella; Ann Michelini; Charlie S Fuchs
A Phase II trial of vinorelbine in patients with advanced gastroesophageal adenocarcinoma.
Cancer investigation 2006;24(4):346-50.
2006: Kana Wu; Edward Giovannucci; Celia Byrne; Elizabeth A Platz; Charlie S Fuchs; Walter C Willett; Rashmi Sinha
Meat mutagens and risk of distal colon adenoma in a cohort of U.S. men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(6):1120-5.
2006: Brian C Jacobson; Samuel C Somers; Charlie S Fuchs; Ciarán P Kelly; Carlos A Camargo
Body-mass index and symptoms of gastroesophageal reflux in women.
The New England journal of medicine 2006;354(22):2340-8.
2006: Gregory J Tranah; James M. Bugni; Edward Giovannucci; Jing Ma; Charlie S Fuchs; Lisa Hines; Leona D Samson; David J Hunter
O6-methylguanine-DNA methyltransferase Leu84Phe and Ile143Val polymorphisms and risk of colorectal cancer in the Nurses' Health Study and Physicians' Health Study (United States).
Cancer causes & control : CCC 2006;17(5):721-31.
2006: Jeffrey A Meyerhardt; Denise Heseltine; Shuji Ogino; jeffrey clark; Peter C Enzinger; David P Ryan; Craig C Earle; Andrew X Zhu; Charlie S Fuchs
Efficacy of cetuximab after treatment with oral epidermal growth factor receptor tyrosine kinase inhibitor-based chemotherapy in metastatic colorectal cancer.
Clinical colorectal cancer 2006;6(1):59-65.
2006: Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Mami Cantor; Gregory J Kirkner; Donna Spiegelman; Michael G Makrigiorgos; Daniel J Weisenberger; Peter W Laird; Massimo Loda; Charlie S Fuchs
Precision and performance characteristics of bisulfite conversion and real-time PCR (MethyLight) for quantitative DNA methylation analysis.
The Journal of molecular diagnostics : JMD 2006;8(2):209-17.
2006: Jeffrey A Meyerhardt; Andrew X Zhu; Peter C Enzinger; David P Ryan; jeffrey clark; Matthew H Kulke; Craig C Earle; Michele Vincitore; Ann Michelini; Susan Sheehan; Charlie S Fuchs
Phase II study of capecitabine, oxaliplatin, and erlotinib in previously treated patients with metastastic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(12):1892-7.
2006: Edward Giovannucci; Yan Liu; Eric B Rimm; Bruce W Hollis; Charlie S Fuchs; Meir J Stampfer; Walter C Willett
Prospective study of predictors of vitamin D status and cancer incidence and mortality in men.
Journal of the National Cancer Institute 2006;98(7):451-9.
2006: Matthew H Kulke; Bingyan Wu; jeffrey clark; Peter C Enzinger; Thomas J Lynch; Michele Vincitore; Ann Michelini; Charlie S Fuchs
A phase II study of doxorubicin, cisplatin, and 5-fluorouracil in patients with advanced adenocarcinoma of the stomach or esophagus.
Cancer investigation 2006;24(3):229-34.
2006: Esther K Wei; Jing Ma; Michael N Pollak; Nader Rifai; Charlie S Fuchs; Susan E Hankinson; Edward Giovannucci
C-peptide, insulin-like growth factor binding protein-1, glycosylated hemoglobin, and the risk of distal colorectal adenoma in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2006;15(4):750-5.
2006: Karin B Michels; Edward Giovannucci; Andrew T Chan; Rohit Singhania; Charlie S Fuchs; Walter C Willett
Fruit and vegetable consumption and colorectal adenomas in the Nurses' Health Study.
Cancer research 2006;66(7):3942-53.
2006: Jaffer A Ajani; Tanios Bekaii-Saab; Thomas A D'Amico; Charlie S Fuchs; Michael K Gibson; Melvyn Goldberg; James A Hayman; David H Ilson; Milind Javle; Scott Kelley; Robert C Kurtz; Gershon Yehuda Locker; Neal J Meropol; Bruce D Minsky; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Jack Roth; Aaron R Sasson; Stephen G Swisher; Douglas E Wood; Yun Yen
Gastric Cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):350-66.
2006: Jaffer A Ajani; Tanios Bekaii-Saab; Thomas A D'Amico; Charlie S Fuchs; Michael K Gibson; Melvyn Goldberg; James A Hayman; David H Ilson; Milind Javle; Scott Kelley; Robert C Kurtz; Gershon Yehuda Locker; Neal J Meropol; Bruce D Minsky; Mark B Orringer; Raymond U Osarogiagbon; James A Posey; Jack Roth; Aaron R Sasson; Stephen G Swisher; Douglas E Wood; Yun Yen
Esophageal Cancer Clinical Practice Guidelines.
Journal of the National Comprehensive Cancer Network : JNCCN 2006;4(4):328-47.
2006: Andrew T Chan; JoAnn E Manson; Christine M Albert; Claudia U Chae; Kathryn M Rexrode; Gary C Curhan; Eric B Rimm; Walter C Willett; Charlie S Fuchs
Nonsteroidal antiinflammatory drugs, acetaminophen, and the risk of cardiovascular events.
Circulation 2006;113(12):1578-87.
2006: Eva S Schernhammer; Gregory J Tranah; Edward Giovannucci; A T Chan; Jing Ma; GRaham Colditz; David J Hunter; Walter C Willett; Charlie S Fuchs
Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
British journal of cancer 2006;94(6):928-34.
2006: A David McCollum; Bingyan Wu; jeffrey clark; Matthew H Kulke; Peter C Enzinger; David P Ryan; Craig C Earle; Ann Michelini; Charlie S Fuchs
The combination of capecitabine and thalidomide in previously treated, refractory metastatic colorectal cancer.
American journal of clinical oncology 2006;29(1):40-4.
2006: Matthew H Kulke; Keith Stuart; Peter C Enzinger; David P Ryan; jeffrey clark; Alona Muzikansky; Michele Vincitore; Ann Michelini; Charlie S Fuchs
Phase II study of temozolomide and thalidomide in patients with metastatic neuroendocrine tumors.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):401-6.
2006: Shuji Ogino; Mohan Brahmandam; Mami Cantor; Chungdak Namgyal; Takako Kawasaki; Gregory J Kirkner; Jeffrey A Meyerhardt; Massimo Loda; Charlie S Fuchs
Distinct molecular features of colorectal carcinoma with signet ring cell component and colorectal carcinoma with mucinous component.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc 2006;19(1):59-68.
2005: Yikyung Park; David J Hunter; Donna Spiegelman; Leif Bergkvist; Franco Berrino; Piet A van den Brandt; Julie E Buring; GRaham Colditz; Jo L Freudenheim; Charlie S Fuchs; Edward Giovannucci; R Alexandra Goldbohm; Saxon Graham; Lisa Harnack; Anne M Hartman; David R Jacobs; Ikuko Kato; Vittorio Krogh; Michael F Leitzmann; Marjorie L McCullough; Anthony B Miller; Pirjo Pietinen; Thomas E Rohan; Arthur Schatzkin; Walter C Willett; Alicja Wolk; Anne Zeleniuch-Jacquotte; Shumin M Zhang; Stephanie A Smith-Warner
Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies.
JAMA : the journal of the American Medical Association 2005;294(22):2849-57.
2005: Richard M Goldberg; Herbert I Hurwitz; Charlie S Fuchs
Angiogenesis inhibition in the treatment of colorectal cancer Part 3 of a 3-part series: targeting VEGF--current and future research directions.
Clinical advances in hematology & oncology : H&O 2005;3(12):1-10; quiz 11.
2005: Peter C Enzinger; Matthew H Kulke; jeffrey clark; David P Ryan; Haesook T Kim; Craig C Earle; Michele Vincitore; Ann Michelini; Robert J Mayer; Charlie S Fuchs
A phase II trial of irinotecan in patients with previously untreated advanced esophageal and gastric adenocarcinoma.
Digestive diseases and sciences 2005;50(12):2218-23.
2005: Jeffrey A Meyerhardt; Denise Heseltine; HANNIA CAMPOS; Michelle D Holmes; Walter C Willett; Eric P Winer; Peter C Enzinger; Craig A Bunnell; Matthew H Kulke; Charlie S Fuchs
Assessment of a dietary questionnaire in cancer patients receiving cytotoxic chemotherapy.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(33):8453-60.
2005: Esther K Wei; Edward Giovannucci; Charlie S Fuchs; Walter C Willett; Christos S Mantzoros
Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study.
Journal of the National Cancer Institute 2005;97(22):1688-94.
2005: Dominique S Michaud; Charlie S Fuchs
Obesity and pancreatic cancer: overall evidence and latency period.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(11 Pt 1):2678; author reply 2678-9.
2005: Candyce H Kroenke; Gary Bennett; Charlie S Fuchs; Ed Giovannucci; Ichiro Kawachi; Eva S Schernhammer; Michelle D Holmes; Laura D Kubzansky
Depressive symptoms and prospective incidence of colorectal cancer in women.
American journal of epidemiology 2005;162(9):839-48.
2005: Keith T Flaherty; Charlie S Fuchs; GRaham Colditz; Meir J Stampfer; Frank E Speizer; Walter C Willett; Gary C Curhan
A prospective study of body mass index, hypertension, and smoking and the risk of renal cell carcinoma (United States).
Cancer causes & control : CCC 2005;16(9):1099-106.
2005: bruce hillner; Deborah Schrag; Daniel J Sargent; Charlie S Fuchs; Richard M Goldberg
Cost-effectiveness projections of oxaliplatin and infusional fluorouracil versus irinotecan and bolus fluorouracil in first-line therapy for metastatic colorectal carcinoma.
Cancer 2005;104(9):1871-84.
2005: John Z Ayanian; Alan M Zaslavsky; Edward Guadagnoli; Charlie S Fuchs; Kathleen J Yost; Cynthia M Creech; Rosemary D Cress; Lilia C O'Connor; Dee W West; William E Wright
Patients' perceptions of quality of care for colorectal cancer by race, ethnicity, and language.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(27):6576-86.
2005: Shuji Ogino; Jeffrey A Meyerhardt; Mami Cantor; Mohan Brahmandam; jeffrey clark; Chungdak Namgyal; Takako Kawasaki; Kate Kinsella; Ann Michelini; Peter C Enzinger; Matthew H Kulke; David P Ryan; Massimo Loda; Charlie S Fuchs
Molecular alterations in tumors and response to combination chemotherapy with gefitinib for advanced colorectal cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6650-6.
2005: Andrew T Chan; Charlie S Fuchs
Do cyclo-oxygenase 2 inhibitors increase the risk of cardiovascular events?
Nature clinical practice. Oncology 2005;2(9):434-5.
2005: Eva S Schernhammer; Frank B Hu; Ed Giovannucci; Dominique S Michaud; GRaham Colditz; Meir J Stampfer; Charlie S Fuchs
Sugar-sweetened soft drink consumption and risk of pancreatic cancer in two prospective cohorts.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(9):2098-105.
2005: Gregory J Tranah; Andrew T Chan; Edward Giovannucci; Jing Ma; Charlie S Fuchs; David J Hunter
Epoxide hydrolase and CYP2C9 polymorphisms, cigarette smoking, and risk of colorectal carcinoma in the Nurses' Health Study and the Physicians' Health Study.
Molecular carcinogenesis 2005;44(1):21-30.
2005: Andrew T Chan; Edward L Giovannucci; Jeffrey A Meyerhardt; Eva S Schernhammer; Gary C Curhan; Charlie S Fuchs
Long-term use of aspirin and nonsteroidal anti-inflammatory drugs and risk of colorectal cancer.
JAMA : the journal of the American Medical Association 2005;294(8):914-23.
2005: Shuji Ogino; Takako Kawasaki; Mohan Brahmandam; Liying Yan; Mami Cantor; Chungdak Namgyal; Mari Mino-Kenudson; Gregory Y Lauwers; Massimo Loda; Charlie S Fuchs
Sensitive sequencing method for KRAS mutation detection by Pyrosequencing.
The Journal of molecular diagnostics : JMD 2005;7(3):413-21.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Anal canal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):510-5.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Rectal cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):492-508.
2005: Paul F Engstrom; Al B Benson; Yi-Jen Chen; Michael A Choti; Raza A Dilawari; Charles A Enke; Marwan G Fakih; Charlie S Fuchs; Krystyna Kiel; James A Knol; Lucille A Leong; Kirk A Ludwig; Edward W Martin; Sujata Rao; Muhammad Wasif Saif; Leonard B Saltz; John M Skibber; Alan P Venook; Timothy J Yeatman
Colon cancer clinical practice guidelines in oncology.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(4):468-91.
2005: Andrew T Chan; Gregory J Tranah; Edward L Giovannucci; Walter C Willett; David J Hunter; Charlie S Fuchs
Prospective study of N-acetyltransferase-2 genotypes, meat intake, smoking and risk of colorectal cancer.
International journal of cancer. Journal international du cancer 2005;115(4):648-52.
2005: Andrew T Chan; Jing Ma; Gregory J Tranah; Edward L Giovannucci; Nader Rifai; David J Hunter; Charlie S Fuchs
Hemochromatosis gene mutations, body iron stores, dietary iron, and risk of colorectal adenoma in women.
Journal of the National Cancer Institute 2005;97(12):917-26.
2005: Andrew X Zhu; Charlie S Fuchs; jeffrey clark; Alona Muzikansky; Kerry Taylor; Susan Sheehan; Kayao Tam; Elizabeth Yung; Matthew H Kulke; David P Ryan
A phase II study of epirubicin and thalidomide in unresectable or metastatic hepatocellular carcinoma.
The oncologist 2005;10(6):392-8.
2005: Jeffrey A Meyerhardt; Jeffrey A Sloan; Daniel J Sargent; Richard M Goldberg; Michael Pollak; Roscoe F Morton; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Charlie S Fuchs
Associations between plasma insulin-like growth factor proteins and C-peptide and quality of life in patients with metastatic colorectal cancer.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(6):1402-10.
2005: Esther K Wei; Edward Giovannucci; Jacob Selhub; Charlie S Fuchs; Susan E Hankinson; Jing Ma
Plasma vitamin B6 and the risk of colorectal cancer and adenoma in women.
Journal of the National Cancer Institute 2005;97(9):684-92.
2005: Dominique S Michaud; Halcyon Skinner; Kana Wu; Frank Hu; Edward Giovannucci; Walter C Willett; GRaham Colditz; Charlie S Fuchs
Dietary patterns and pancreatic cancer risk in men and women.
Journal of the National Cancer Institute 2005;97(7):518-24.
2005: Gregory J Tranah; Edward Giovannucci; Jing Ma; Charlie S Fuchs; David J Hunter
APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):863-70.
2005: Esther K Wei; Jing Ma; Michael N Pollak; Nader Rifai; Charlie S Fuchs; Susan E Hankinson; Edward Giovannucci
A prospective study of C-peptide, insulin-like growth factor-I, insulin-like growth factor binding protein-1, and the risk of colorectal cancer in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):850-5.
2005: Karin B Michels; Charlie S Fuchs; Edward Giovannucci; GRaham Colditz; David J Hunter; Meir J Stampfer; Walter C Willett
Fiber intake and incidence of colorectal cancer among 76,947 women and 47,279 men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):842-9.
2005: Kyungwon Oh; Walter C Willett; Charlie S Fuchs; Edward Giovannucci
Dietary marine n-3 fatty acids in relation to risk of distal colorectal adenoma in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(4):835-41.
2005: Andrew T Chan; Gregory J Tranah; Edward L Giovannucci; David J Hunter; Charlie S Fuchs
Genetic variants in the UGT1A6 enzyme, aspirin use, and the risk of colorectal adenoma.
Journal of the National Cancer Institute 2005;97(6):457-60.
2005: Karin B Michels; Walter C Willett; Charlie S Fuchs; Edward Giovannucci
Coffee, tea, and caffeine consumption and incidence of colon and rectal cancer.
Journal of the National Cancer Institute 2005;97(4):282-92.
2005: Dominique S Michaud; Charlie S Fuchs; Simin Liu; Walter C Willett; GRaham Colditz; Edward Giovannucci
Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2005;14(1):138-47.
2004: Jeffrey A Meyerhardt; Charlie S Fuchs
Epidermal growth factor receptor inhibitors and colorectal cancer.
Oncology (Williston Park, N.Y.) 2004;18(14 Suppl 14):35-8.
2004: Jia Chen; Charles Kyte; Wendy Chan; James G Wetmur; Charlie S Fuchs; Edward Giovannucci
Polymorphism in the thymidylate synthase promoter enhancer region and risk of colorectal adenomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(12):2247-50.
2004: Craig C Earle; Ambrose Kwok; G Scott Gazelle; Charlie S Fuchs
Two schedules of second-line irinotecan for metastatic colon carcinoma.
Cancer 2004;101(11):2533-9.
2004: Thierry Delaunoit; Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Brian P Findlay; Sachdev P Thomas; Muhammad Salim; Paul L Schaefer; Philip J Stella; Erin Green; James A Mailliard
Mortality associated with daily bolus 5-fluorouracil/leucovorin administered in combination with either irinotecan or oxaliplatin: results from Intergroup Trial N9741.
Cancer 2004;101(10):2170-6.
2004: Kana Wu; Frank B Hu; Charlie S Fuchs; Eric B Rimm; Walter C Willett; Edward Giovannucci
Dietary patterns and risk of colon cancer and adenoma in a cohort of men (United States).
Cancer causes & control : CCC 2004;15(9):853-62.
2004: A David McCollum; Matthew H Kulke; David P Ryan; jeffrey clark; Larry N Shulman; Robert J Mayer; Sylvia Bartel; Charlie S Fuchs
Lack of efficacy of streptozocin and doxorubicin in patients with advanced pancreatic endocrine tumors.
American journal of clinical oncology 2004;27(5):485-8.
2004: Diane Feskanich; Jing Ma; Charlie S Fuchs; Gregory J Kirkner; Susan E Hankinson; Bruce W Hollis; Edward L Giovannucci
Plasma vitamin D metabolites and risk of colorectal cancer in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(9):1502-8.
2004: Matthew H Kulke; Haesook T Kim; jeffrey clark; Peter C Enzinger; Thomas J Lynch; Jeffrey A Morgan; Michele Vincitore; Ann Michelini; Charlie S Fuchs
A Phase II trial of gemcitabine for metastatic neuroendocrine tumors.
Cancer 2004;101(5):934-9.
2004: Andrew T Chan; Gregory J Tranah; Edward L Giovannucci; David J Hunter; Charlie S Fuchs
A prospective study of genetic polymorphisms in the cytochrome P-450 2C9 enzyme and the risk for distal colorectal adenoma.
Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association 2004;2(8):704-12.
2004: Halcyon Skinner; Dominique S Michaud; Edward L Giovannucci; Eric B Rimm; Meir J Stampfer; Walter C Willett; GRaham Colditz; Charlie S Fuchs
A prospective study of folate intake and the risk of pancreatic cancer in men and women.
American journal of epidemiology 2004;160(3):248-58.
2004: Kyungwon Oh; Walter C Willett; Charlie S Fuchs; Edward L Giovannucci
Glycemic index, glycemic load, and carbohydrate intake in relation to risk of distal colorectal adenoma in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(7):1192-8.
2004: Gregory J Tranah; Edward Giovannucci; Jing Ma; Charlie S Fuchs; Susan E Hankinson; David J Hunter
Epoxide hydrolase polymorphisms, cigarette smoking and risk of colorectal adenoma in the Nurses' Health Study and the Health Professionals Follow-up Study.
Carcinogenesis 2004;25(7):1211-8.
2004: Kathleen M Fairfield; David J Hunter; GRaham Colditz; Charlie S Fuchs; Daniel W Cramer; Frank E Speizer; Walter C Willett; Susan E Hankinson
A prospective study of dietary lactose and ovarian cancer.
International journal of cancer. Journal international du cancer 2004;110(2):271-7.
2004: Gregory J Tranah; Edward Giovannucci; Jing Ma; Charlie S Fuchs; Susan E Hankinson; David J Hunter
XRCC2 and XRCC3 polymorphisms are not associated with risk of colorectal adenoma.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2004;13(6):1090-1.
2004: Jeffrey A Meyerhardt; Ambrose Kwok; Mark J Ratain; J Patrick McGovren; Charlie S Fuchs
Relationship of baseline serum bilirubin to efficacy and toxicity of single-agent irinotecan in patients with metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(8):1439-46.
2004: David P Ryan; Joseph P Eder; Thomas Puchlaski; Michael Seiden; Thomas J Lynch; Charlie S Fuchs; Philip C Amrein; Daryl S Sonnichsen; Jeffrey G Supko; jeffrey clark
Phase I clinical trial of the farnesyltransferase inhibitor BMS-214662 given as a 1-hour intravenous infusion in patients with advanced solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(7):2222-30.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; A David McCollum; Denise Brady; Michael J O'Connell; Robert J Mayer; Bernard Cummings; Christopher Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of body mass index on outcomes and treatment-related toxicity in patients with stage II and III rectal cancer: findings from Intergroup Trial 0114.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(4):648-57.
2004: Andrew T Chan; Edward L Giovannucci; Eva S Schernhammer; GRaham Colditz; David J Hunter; Walter C Willett; Charlie S Fuchs
A prospective study of aspirin use and the risk for colorectal adenoma.
Annals of internal medicine 2004;140(3):157-66.
2004: Esther K Wei; Edward Giovannucci; Kana Wu; Bernard Rosner; Charlie S Fuchs; Walter C Willett; GRaham Colditz
Comparison of risk factors for colon and rectal cancer.
International journal of cancer. Journal international du cancer 2004;108(3):433-42.
2004: Eva S Schernhammer; Jae-Hee Kang; Andrew T Chan; Dominique S Michaud; Halcyon Skinner; Edward Giovannucci; GRaham Colditz; Charlie S Fuchs
A prospective study of aspirin use and the risk of pancreatic cancer in women.
Journal of the National Cancer Institute 2004;96(1):22-8.
2004: Matthew H Kulke; Haesook T Kim; Keith Stuart; jeffrey clark; David P Ryan; Michele Vincitore; Robert J Mayer; Charlie S Fuchs
A phase II study of docetaxel in patients with metastatic carcinoid tumors.
Cancer investigation 2004;22(3):353-9.
2004: Jeffrey A Meyerhardt; Joel E Tepper; Donna Niedzwiecki; Donna Hollis; Deborah Schrag; John Z Ayanian; Michael J O'Connell; Jane C Weeks; Robert J Mayer; Christopher G Willett; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of hospital procedure volume on surgical operation and long-term outcomes in high-risk curatively resected rectal cancer: findings from the Intergroup 0114 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):166-74.
2004: Richard M Goldberg; Daniel J Sargent; Roscoe F Morton; Charlie S Fuchs; Ramesh K Ramanathan; Stephen K Williamson; Brian P Findlay; Henry C Pitot; Steven R Alberts
A randomized controlled trial of fluorouracil plus leucovorin, irinotecan, and oxaliplatin combinations in patients with previously untreated metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(1):23-30.
2003: Balraj S Jhawar; Charlie S Fuchs; GRaham Colditz; Meir J Stampfer
Sex steroid hormone exposures and risk for meningioma.
Journal of neurosurgery 2003;99(5):848-53.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Deborah Schrag; John Z Ayanian; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Association of hospital procedure volume and outcomes in patients with colon cancer at high risk for recurrence.
Annals of internal medicine 2003;139(8):649-57.
2003: Edward Giovannucci; Jia Chen; Stephanie A Smith-Warner; Eric B Rimm; Charlie S Fuchs; Caroline Palomeque; Walter C Willett; David J Hunter
Methylenetetrahydrofolate reductase, alcohol dehydrogenase, diet, and risk of colorectal adenomas.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(10):970-9.
2003: Paulo M Hoff; Charlie S Fuchs
The experience with oxaliplatin in the treatment of upper gastrointestinal carcinomas.
Seminars in oncology 2003;30(4 Suppl 15):54-61.
2003: Charlie S Fuchs
Current and ongoing trials with irinotecan in the United States.
Seminars in oncology 2003;30(4 Suppl 12):9-17.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Daniel G Haller; Robert J Mayer; Al B Benson; John S Macdonald; Charlie S Fuchs
Influence of body mass index on outcomes and treatment-related toxicity in patients with colon carcinoma.
Cancer 2003;98(3):484-95.
2003: Dominique S Michaud; Edward Giovannucci; Walter C Willett; GRaham Colditz; Charlie S Fuchs
Dietary meat, dairy products, fat, and cholesterol and pancreatic cancer risk in a prospective study.
American journal of epidemiology 2003;157(12):1115-25.
2003: Eva S Schernhammer; Andrea Abu-Akel; Frank E Speizer; Walter C Willett; David J Hunter; Ichiro Kawachi; Charlie S Fuchs; GRaham Colditz
Night-shift work and risk of colorectal cancer in the nurses' health study.
Journal of the National Cancer Institute 2003;95(11):825-8.
2003: David C Hodgson; Wei Zhang; Alan M Zaslavsky; Charlie S Fuchs; William E Wright; John Z Ayanian
Relation of hospital volume to colostomy rates and survival for patients with rectal cancer.
Journal of the National Cancer Institute 2003;95(10):708-16.
2003: Jeffrey A Meyerhardt; Charlie S Fuchs
Adjuvant therapy in gastric cancer: can we prevent recurrences?
Oncology (Williston Park, N.Y.) 2003;17(5):714-21, 728; discussion 728-9, 732-3.
2003: Halcyon Skinner; Dominique S Michaud; GRaham Colditz; Edward L Giovannucci; Meir J Stampfer; Walter C Willett; Charlie S Fuchs
Parity, reproductive factors, and the risk of pancreatic cancer in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2003;12(5):433-8.
2003: John Z Ayanian; Alan M Zaslavsky; Charlie S Fuchs; Edward Guadagnoli; Cynthia M Creech; Rosemary D Cress; Lilia C O'Connor; Dee W West; Mark E Allen; Robert E Wolf; William E Wright
Use of adjuvant chemotherapy and radiation therapy for colorectal cancer in a population-based cohort.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(7):1293-300.
2003: Charlie S Fuchs; Melvin R Moore; Graydon Harker; Luis Villa; David Rinaldi; J Randolph Hecht
Phase III comparison of two irinotecan dosing regimens in second-line therapy of metastatic colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(5):807-14.
2003: Teresa Fung; Frank B Hu; Charlie S Fuchs; Edward Giovannucci; David J Hunter; Meir J Stampfer; GRaham Colditz; Walter C Willett
Major dietary patterns and the risk of colorectal cancer in women.
Archives of internal medicine 2003;163(3):309-14.
2003: Jeffrey A Meyerhardt; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Impact of diabetes mellitus on outcomes in patients with colon cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(3):433-40.
2003: Eva S Schernhammer; Michael F Leitzmann; Dominique S Michaud; Frank E Speizer; Edward Giovannucci; GRaham Colditz; Charlie S Fuchs
Cholecystectomy and the risk for developing colorectal cancer and distal colorectal adenomas.
British journal of cancer 2003;88(1):79-83.
2003: David P Ryan; jeffrey clark; Matthew H Kulke; Charlie S Fuchs; Craig C Earle; Peter C Enzinger; Keith Stuart; Keith J Catarius; Jennifer Winkelmann; Robert J Mayer
A phase II study of modified deGramont 5-fluorouracil, leucovorin, and oxaliplatin in previously treated patients with metastatic colorectal cancer.
Cancer investigation 2003;21(4):505-11.
2003: M Dror Michaelson; David P Ryan; Charlie S Fuchs; Jeffrey G Supko; Rocio Garcia-Carbonero; J Paul Eder; jeffrey clark
A Phase I study of 9-nitrocamptothecin given concurrently with capecitabine in patients with refractory, metastatic solid tumors.
Cancer 2003;97(1):148-54.
2002: Kana Wu; Walter C Willett; June M Chan; Charlie S Fuchs; GRaham Colditz; Eric B Rimm; Edward L Giovannucci
A prospective study on supplemental vitamin e intake and risk of colon cancer in women and men.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(11):1298-304.
2002: Dominique S Michaud; Simin Liu; Edward Giovannucci; Walter C Willett; GRaham Colditz; Charlie S Fuchs
Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study.
Journal of the National Cancer Institute 2002;94(17):1293-300.
2002: Matthew H Kulke; George D Demetri; Norman E Sharpless; David P Ryan; Ramesh A Shivdasani; Jeffrey S Clark; Bruce M Spiegelman; Haesook T Kim; Robert J Mayer; Charlie S Fuchs
A phase II study of troglitazone, an activator of the PPARgamma receptor, in patients with chemotherapy-resistant metastatic colorectal cancer.
Cancer journal (Sudbury, Mass.) 2002;8(5):395-9.
2002: A David McCollum; Paul J Catalano; Daniel G Haller; Robert J Mayer; John S Macdonald; Al B Benson; Charlie S Fuchs
Outcomes and toxicity in african-american and caucasian patients in a randomized adjuvant chemotherapy trial for colon cancer.
Journal of the National Cancer Institute 2002;94(15):1160-7.
2002: Kathleen M Fairfield; David J Hunter; Charlie S Fuchs; GRaham Colditz; Susan E Hankinson
Aspirin, other NSAIDs, and ovarian cancer risk (United States).
Cancer causes & control : CCC 2002;13(6):535-42.
2002: Robert B Lobell; Dongming Liu; Carolyn A Buser; Joseph P Davide; Elizabeth DePuy; Kelly Hamilton; Kenneth S Koblan; Yih Lee; Scott D Mosser; Sherri L Motzel; James L Abbruzzese; Charlie S Fuchs; Eric K Rowinsky; Eric H Rubin; Sunil Sharma; Paul J Deutsch; Kathryn E Mazina; Briggs W Morrison; Lynne Wildonger; Siu-Long Yao; Nancy E Kohl
Preclinical and clinical pharmacodynamic assessment of L-778,123, a dual inhibitor of farnesyl:protein transferase and geranylgeranyl:protein transferase type-I.
Molecular cancer therapeutics 2002;1(9):747-58.
2002: Charlie S Fuchs; jeffrey clark; David P Ryan; Matthew H Kulke; Haesook T Kim; Craig C Earle; Michele Vincitore; Robert J Mayer; Keith E Stuart
A phase II trial of gemcitabine in patients with advanced hepatocellular carcinoma.
Cancer 2002;94(12):3186-91.
2002: Melenda Jeter; Pasi A Janne; Sarah Brooks; Harold J Burstein; Patrick Y Wen; Charlie S Fuchs; Jay S Loeffler; Phillip M Devlin; Ravi Salgia
Gemcitabine-induced radiation recall.
International journal of radiation oncology, biology, physics 2002;53(2):394-400.
2002: Eva S Schernhammer; Dominique S Michaud; Michael F Leitzmann; Edward Giovannucci; GRaham Colditz; Charlie S Fuchs
Gallstones, cholecystectomy, and the risk for developing pancreatic cancer.
British journal of cancer 2002;86(7):1081-4.
2002: Jeffrey A Meyerhardt; Charlie S Fuchs
Chemotherapy options for gastric cancer.
Seminars in radiation oncology 2002;12(2):176-86.
2002: Kana Wu; Walter C Willett; Charlie S Fuchs; GRaham Colditz; Edward L Giovannucci
Calcium intake and risk of colon cancer in women and men.
Journal of the National Cancer Institute 2002;94(6):437-46.
2002: Charlie S Fuchs; Walter C Willett; GRaham Colditz; David J Hunter; Meir J Stampfer; Frank E Speizer; Edward L Giovannucci
The influence of folate and multivitamin use on the familial risk of colon cancer in women.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2002;11(3):227-34.
2002: Karin B Michels; E Giovannucci; K J Joshipura; Bernard A Rosner; M J Stampfer; Charlie S Fuchs; GRaham Colditz; F E Speizer; W C Willett
Fruit and vegetable consumption and colorectal cancer incidence.
IARC scientific publications 2002;156():139-40.
2002: David P Ryan; Matthew H Kulke; Charlie S Fuchs; Michael L Grossbard; Steven R Grossman; Jeffrey A Morgan; Craig C Earle; Ramesh A Shivdasani; Haesook T Kim; Robert J Mayer; jeffrey clark
A Phase II study of gemcitabine and docetaxel in patients with metastatic pancreatic carcinoma.
Cancer 2002;94(1):97-103.
2001: D S Michaud; E Giovannucci; W C Willett; GRaham Colditz; M J Stampfer; Charlie S Fuchs
Physical activity, obesity, height, and the risk of pancreatic cancer.
JAMA : the journal of the American Medical Association 2001;286(8):921-9.
2001: E R Bertone; Walter C Willett; Bernard A Rosner; David J Hunter; Charlie S Fuchs; Frank E Speizer; GRaham Colditz; Susan E Hankinson
Prospective study of recreational physical activity and ovarian cancer.
Journal of the National Cancer Institute 2001;93(12):942-8.
2001: Dominique S Michaud; Edward Giovannucci; Walter C Willett; GRaham Colditz; Charlie S Fuchs
Coffee and alcohol consumption and the risk of pancreatic cancer in two prospective United States cohorts.
Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2001;10(5):429-37.
2001: David C Hodgson; Charlie S Fuchs; John Z Ayanian
Impact of patient and provider characteristics on the treatment and outcomes of colorectal cancer.
Journal of the National Cancer Institute 2001;93(7):501-15.
2000: Charlie S Fuchs
Colorectal cancer: treatment considerations.
Health news (Waltham, Mass.) 2000;6(11):1-2.
2000: Karin B Michels; K J Joshipura; Bernard A Rosner; Meir J Stampfer; Charlie S Fuchs; GRaham Colditz; Frank E Speizer; Walter C Willett
Prospective study of fruit and vegetable consumption and incidence of colon and rectal cancers.
Journal of the National Cancer Institute 2000;92(21):1740-52.
2000: Lindsay Frazier; GRaham Colditz; Charlie S Fuchs; K M Kuntz
Cost-effectiveness of screening for colorectal cancer in the general population.
JAMA : the journal of the American Medical Association 2000;284(15):1954-61.
2000: Laurent Dukas; Walter C Willett; GRaham Colditz; Charlie S Fuchs; Bernard Rosner; Edward L Giovannucci
Prospective study of bowel movement, laxative use, and risk of colorectal cancer among women.
American journal of epidemiology 2000;151(10):958-64.
2000: D P Ryan; Thomas J Lynch; M L Grossbard; Michael Seiden; Charlie S Fuchs; N Grenon; P Baccala; D Berg; D Finkelstein; Robert J Mayer; jeffrey clark
A phase I study of gemcitabine and docetaxel in patients with metastatic solid tumors.
Cancer 2000;88(1):180-5.
1999: Shumin M Zhang; David J Hunter; Bernard A Rosner; GRaham Colditz; Charlie S Fuchs; Frank E Speizer; Walter C Willett
Dietary fat and protein in relation to risk of non-Hodgkin's lymphoma among women.
Journal of the National Cancer Institute 1999;91(20):1751-8.
1999: Charlie S Fuchs; E L Giovannucci; GRaham Colditz; David J Hunter; Meir J Stampfer; B Rosner; Frank E Speizer; Walter C Willett
Dietary fiber and the risk of colorectal cancer and adenoma in women.
The New England journal of medicine 1999;340(3):169-76.
1998: A M Kavanagh; Edward L Giovannucci; Charlie S Fuchs; GRaham Colditz
Screening endoscopy and risk of colorectal cancer in United States men.
Cancer causes & control : CCC 1998;9(4):455-62.
1997: Elizabeth A Platz; Maria Elena Martinez; Francine Grodstein; Charlie S Fuchs; GRaham Colditz; Meir J Stampfer; Edward Giovannucci
Parity and other reproductive factors and risk of adenomatous polyps of the distal colorectum (United States).
Cancer causes & control : CCC 1997;8(6):894-903.
1997: Charlie S Fuchs
Chemotherapy for advanced gastric cancer: where do we stand?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(11):3299-300.
1996: Charlie S Fuchs
Progress in rectal cancer.
Lancet 1996;348(9042):1600.
1996: Charlie S Fuchs; GRaham Colditz; Meir J Stampfer; Edward L Giovannucci; D J Hunter; Eric B Rimm; Walter C Willett; Frank E Speizer
A prospective study of cigarette smoking and the risk of pancreatic cancer.
Archives of internal medicine 1996;156(19):2255-60.
1995: Charlie S Fuchs; Robert J Mayer
Adjuvant chemotherapy for colon and rectal cancer.
Seminars in oncology 1995;22(5):472-87.
1995: Charlie S Fuchs; Robert J Mayer
Gastric carcinoma.
The New England journal of medicine 1995;333(1):32-41.
1995: Charlie S Fuchs; M J Stampfer; GRaham Colditz; Edward L Giovannucci; JoAnn E Manson; I Kawachi; D J Hunter; Susan E Hankinson; C H Hennekens; B Rosner
Alcohol consumption and mortality among women.
The New England journal of medicine 1995;332(19):1245-50.
1994: Charlie S Fuchs; Edward L Giovannucci; GRaham Colditz; David J Hunter; Frank E Speizer; Walter C Willett
A prospective study of family history and the risk of colorectal cancer.
The New England journal of medicine 1994;331(25):1669-74.
1992: William G Kaelin; W Krek; William R Sellers; James A DeCaprio; Florence Cymbalista; Charlie S Fuchs; T Chittenden; Yi Li; Peggy J Farnham; M A Blanar
Expression cloning of a cDNA encoding a retinoblastoma-binding protein with E2F-like properties.
Cell 1992;70(2):351-64.